When VC Steps Back: Finding Alternative Biotech Funding

When VC Steps Back: Finding Alternative Biotech Funding

Citeline Article quoting Ali Pashazadeh, Treehill Partners CEO

“In order for you to have alternate funding solution, you need to have an alternate offering, which means that you need to have an alternate business model that then attracts that capital” – Treehill Partners CEO Ali Pashazadeh shares detailed comments around evolving and innovative financing pathways in the biotech sector.

Read the full article on Citeline Commercial’s InVivo publication:

https://insights.citeline.com/in-vivo/growth/when-vc-steps-back-finding-alternative-biotech-funding-4UN5IYJEUZD2XPLYIZ7RR7YVQY

Subscribe to our mailings!

Thank You

Please choose your subscriptions:

Unsubscribe any time using the footer of our emails. For information about our privacy practices, please visit our privacy policy.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.